Frontiers | Assessment of the Effect of Erenumab on Efficacy and Quality-of-Life Parameters in a Cohort of Migraine Patients With Treatment Failure in Cyprus
Migraine prevention with erenumab | TCRM
IJMS | Free Full-Text | Effects of Anti-Calcitonin Gene-Related Peptide for Migraines: A Systematic Review with Meta-Analysis of Randomized Clinical Trials
Frontiers | Erenumab for Migraine Prevention in a 1-Year Compassionate Use Program: Efficacy, Tolerability, and Differences Between Clinical Phenotypes
Early onset of efficacy with erenumab in patients with episodic and chronic migraine | The Journal of Headache and Pain | Full Text
A Controlled Trial of Erenumab for Episodic Migraine ... | GrepMed
Study design of the episodic migraine trial (a) and the chronic... | Download Scientific Diagram
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study - The Lancet
JCM | Free Full-Text | Reducing the Burden of Migraine: Safety and Efficacy of CGRP Pathway-Targeted Preventive Treatments
Effect of erenumab on functional outcomes in patients with episodic migraine in whom 2–4 preventives were not useful: results from the LIBERTY study | Journal of Neurology, Neurosurgery & Psychiatry
A Controlled Trial of Erenumab for Episodic Migraine | NEJM
![PDF] ARISE: A Phase 3 randomized trial of erenumab for episodic migraine | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/57b8c7a7cd9246b7072730224457f3a70d5b4e82/5-Table2-1.png "PDF] ARISE: A Phase 3 randomized trial of erenumab for episodic migraine | Semantic Scholar")
PDF] ARISE: A Phase 3 randomized trial of erenumab for episodic migraine | Semantic Scholar
A Controlled Trial of Erenumab for Episodic Migraine | NEJM
![PDF] Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2b5d2470ef97a1399bd34d281f9f37ddf42e79f0/4-Figure1-1.png "PDF] Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study | Semantic Scholar")
PDF] Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study | Semantic Scholar
Aimovig (erenumab) for the Treatment of Episodic Migraine
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine - David W Dodick, Messoud Ashina, Jan Lewis Brandes, David Kudrow, Michel Lanteri-Minet, Vera Osipova, Kerry Palmer, Hernan Picard, Daniel D
Novartis data show Aimovig® cuts acute migraine medication days by half in patients who failed prior preventive therapies | Novartis
The appropriate dosing of erenumab for migraine prevention after multiple preventive treatment failures: a critical appraisal | The Journal of Headache and Pain | Full Text
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study - The Lancet
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial - The Lancet Neurology
A Controlled Trial of Erenumab for Episodic Migraine | NEJM
Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER study - Shuu-Jiun Wang, Artemio A Roxas, Bibiana Saravia,
